GENE ONLINE|News &
Opinion
Blog

Base Editing
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Singapore Researchers Design New C to G Base Editor to Correct Disease-Associated Mutations
2021-03-18
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
New and Improved Base-Editing Tool Helps Cure Blindness in Mice
2020-10-25
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Base Editing the Cell’s Powerhouse: Bacterial Toxin Could Help Cure Mitochondrial Diseases
2020-07-26
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Successful Gene-Editing to Reverse Deafness Scores Another Win for Gene Therapy
2020-06-07
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
Evolved Base Editor Surpasses Predecessors with High Efficiency and Versatility
2020-03-18
Base Editing Start-up Beams with US$180 Million IPO
2020-02-06
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
Prime Editing: A New Twist in the CRISPR Tale
2019-11-28
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top